John Mcmahon Sells 1,999 Shares of Heska Corp. (HSKA) Stock
Heska Corp. (NASDAQ:HSKA) CFO John Mcmahon sold 1,999 shares of the stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $65.64, for a total value of $131,214.36. Following the completion of the transaction, the chief financial officer now directly owns 584 shares in the company, valued at $38,333.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Heska Corp. (NASDAQ:HSKA) opened at 66.11 on Thursday. The stock has a market cap of $456.03 million, a P/E ratio of 52.93 and a beta of 0.74. The firm’s 50-day moving average price is $58.16 and its 200-day moving average price is $48.46. Heska Corp. has a 12 month low of $26.25 and a 12 month high of $69.80.
Heska Corp. (NASDAQ:HSKA) last announced its quarterly earnings results on Tuesday, November 1st. The company reported $0.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.25 by $0.20. The company earned $33.40 million during the quarter, compared to the consensus estimate of $31.36 million. Heska Corp. had a return on equity of 10.46% and a net margin of 7.55%. The firm’s revenue for the quarter was up 19.3% compared to the same quarter last year. On average, analysts predict that Heska Corp. will post $1.32 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “John Mcmahon Sells 1,999 Shares of Heska Corp. (HSKA) Stock” was originally posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2016/12/01/john-mcmahon-sells-1999-shares-of-heska-corp-hska-stock.html.
A number of hedge funds have recently made changes to their positions in the company. MSI Financial Services Inc acquired a new stake in shares of Heska Corp. during the third quarter worth about $103,000. Bank of Montreal Can purchased a new stake in Heska Corp. during the second quarter worth approximately $128,000. Acrospire Investment Management LLC boosted its stake in Heska Corp. by 786.3% in the second quarter. Acrospire Investment Management LLC now owns 4,396 shares of the company’s stock worth $163,000 after buying an additional 3,900 shares during the period. The Manufacturers Life Insurance Company purchased a new stake in Heska Corp. during the third quarter worth approximately $242,000. Finally, Two Sigma Securities LLC purchased a new stake in Heska Corp. during the third quarter worth approximately $244,000. 72.70% of the stock is owned by institutional investors.
A number of brokerages have recently commented on HSKA. Benchmark Co. began coverage on Heska Corp. in a research note on Tuesday. They issued a “buy” rating and a $78.00 target price on the stock. Sidoti downgraded Heska Corp. from a “buy” rating to a “neutral” rating and set a $71.00 target price on the stock. in a research note on Monday. B. Riley restated a “neutral” rating and issued a $55.50 target price on shares of Heska Corp. in a research note on Monday, November 7th. Finally, Zacks Investment Research upgraded Heska Corp. from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a research note on Wednesday, November 2nd. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Heska Corp. currently has an average rating of “Buy” and an average target price of $66.88.
Heska Corp. Company Profile
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.
Receive News & Stock Ratings for Heska Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corp. and related stocks with our FREE daily email newsletter.